RP-904

N/A

Report date: 2025/02/27 11:08:38
NME

Base Information

Drug NameRP-904
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 1 antagonistsVascular endothelial growth factor receptor 2 antagonistsVascular endothelial growth factor receptor 3 antagonists
TargetsVascular endothelial growth factor receptor 1Vascular endothelial growth factor receptor 2Vascular endothelial growth factor receptor 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRisen (Suzhou) Pharma Tech Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesRisen (Suzhou) Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A